New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2013
07:08 EDTATRCAtriCure price target raised to $19 on acquisition at Canaccord
Canaccord raised AtriCure's price target to $19 from $16 based on the strategic acquisition of privately held Estech. The analyst said Estech has a strong cache of IP in the ablation space with over 200 patents. Shares are Buy rated.
News For ATRC From The Last 14 Days
Check below for free stories on ATRC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 9, 2014
08:24 EDTATRCPiper Jaffray's medtech analysts hold an analyst/industry conference call
The MedTech Analyst Team focuses on Piper Jaffray's covered universe from the perspective of Technical Analyst Johnson ahead of 1Q14 earnings results on an Analyst/Industry conference call to be held on April 11 at 10 am.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use